| Date | Time | Room | Session Title | Presentation Time | Topic | Role |
|---|---|---|---|---|---|---|
| 26/09/2024 | 16:40 to 18:00 | Room 02 |
Congress Gynecology Module Round Table - Special situations in gynecological oncology (40) |
17:00 to 17:20 | Is there any indication for retreatment with immunotherapy after previous use of immunotherapy (alone or in combination) in gynecological tumors? | Speaker |
| 27/09/2024 | 10:00 to 11:20 | Room 02 |
Congress Gynecology Module Round Table - Endometrial cancer (41) |
10:40 to 11:00 | Systemic treatment of advanced endometrial cancer – should chemotherapy in combination with first-line immunotherapy be the standard for all patients? | Speaker |
| 27/09/2024 | 11:40 to 13:00 | Room 02 |
Congress Gynecology Module Round Table - Ovarian cancer (42) |
12:00 to 12:20 | Challenges in the use of iPARP: oligoprogression and the use of iPARP beyond maintenance in the first line of ovarian cancer | Speaker |